They are distinct phenomena with different mechanisms and management approaches
IGF-1 LR3 (Long R3 Insulin-like Growth Factor 1) is a synthetic analog of human IGF-1
Because the peptide was still shown to be effective 14 days post-injury, the researchers suggested that there is increased activity of wound healing mechanisms to increase mechanical strength, as well as an increase in potentiated activity that could lead to beneficial results
The resource library at SeekPeptides continues to grow as new evidence emerges, providing researchers with the most current, evidence-based guidance available
has also served as a consultant, advisory board member and speaker for Abbott Laboratories, Allergan, AstraZeneca, Bristol-Myers Squibb, Cephalon (now Teva Pharmaceutical Industries), Dainippon Sumitomo Pharma, GlaxoSmithKline, H